International Extranodal Lymphoma Study Group (ielsg)
Clinical trials sponsored by International Extranodal Lymphoma Study Group (ielsg), explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can PET scans better predict lymphoma outcomes? Results expected Oct 2026 (estimated)
- New hope for lymphoma patients who Can't take chemo Results expected Dec 2026 (estimated)
- Scientists dive into DNA of rare lymphoma to predict outcomes Results expected Dec 2026 (estimated)
- New hope for marginal zone lymphoma: Chemo-Free combo shows promise Results expected Jun 2027 (estimated)
- New drug cocktail aims to control Hard-to-Treat lymphoma Results expected Sep 2027 (estimated)
-
Scientists create atlas of rare lymphoma to unlock new treatment clues
Knowledge-focused Not yet recruitingThis observational study will analyze tissue samples from 400 people with MALT lymphoma, a slow-growing cancer. Researchers aim to build a comprehensive molecular and cellular map of the disease across different body sites. The goal is to identify tumor subtypes and biomarkers th…
Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists map the genetic secrets of a rare brain cancer to pave the way for smarter treatments
Knowledge-focused Not yet recruitingThis study examines tumor samples from 100 people diagnosed with primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL), a rare cancer that starts in the brain or spine. Researchers will use advanced genetic and molecular techniques to identify patterns in the …
Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC